| 11:41a | JOHNSON & JOHNSON : Janssen to Acquire Investigational Bermekimab from XBiotech | PU |
| 10:38a | XBiotech Shares Jump After Selling Bermekimab to Janssen | DJ |
| 08:17a | JOHNSON & JOHNSON : Janssen Pharmaceutical Companies - IMBRUVICA Combination The.. | AQ |
| 08:17a | JOHNSON & JOHNSON : Janssen Announces BCMA CAR-T Therapy JNJ-4528 Granted U.S. F.. | AQ |
| 06:52a | JOHNSON & JOHNSON : Announces Commitment to Support Republic of Rwanda's Prepare.. | AQ |
| 06:41a | XBIOTECH : Sells Bermekimad to Janssen Biotech | DJ |
| 12/06 | JOHNSON & JOHNSON : Janssen Says Investigational Treatment for Myeloma Gets FDA .. | DJ |
| 12/06 | AMGEN : Says FDA Approves Avsola for Same Indications as Remicade | DJ |
| 12/05 | JOHNSON & JOHNSON : Change in Directors or Principal Officers (form 8-K) | AQ |
| 12/05 | JOHNSON & JOHNSON : Names Hubert Joly, Executive Chairman of Best Buy and Mark A.. | PU |
| 12/05 | JOHNSON & JOHNSON : C O R R E C T I O N -- Johnson & Johnson/ | PR |
| 12/03 | Johnson & Johnson says new tests show no asbestos in Johnson's Baby Powder | RE |
| 12/03 | J&J : Testing Confirms No Asbestos in Baby Powder | DJ |
| 12/03 | JOHNSON & JOHNSON : Company Investigation Confirms No Asbestos in Johnson's Baby.. | PR |
| 12/03 | MOVING BENADRYL BEHIND THE COUNTER D : pharmacists | AQ |
| 12/03 | JOHNSON & JOHNSON : Announces Winners of Champions of Science Storytelling Chall.. | AQ |
| 11/27 | Opioid Makers Hit With Criminal Probe -- WSJ | DJ |
| 11/27 | JOHNSON & JOHNSON : Drugmakers, distributors facing federal opioid probe | AQ |
| 11/26 | Opioid Makers, Distributors Fall Following WSJ Report on Federal Probe | DJ |
| 11/26 | Federal Prosecutors Launch Criminal Probe of Opioid Makers, Distributors | DJ |
| 11/25 | JOHNSON & JOHNSON : Ex-dividend day for | FA |
| 11/22 | The Best-Managed Companies of 2019 -- and How -2- | DJ |
| 11/22 | The Best-Managed Companies of 2019 -- and How They Got That Way -- Journal Re.. | DJ |
| 11/21 | JOHNSON & JOHNSON : Australian judge finds Johnson & Johnson 'negligent' in vagi.. | AQ |
| 11/21 | JOHNSON & JOHNSON : Oklahoma attorney general to appeal judge's opioid ruling | AQ |
| 11/21 | JOHNSON & JOHNSON : Women win landmark class action against Johnson & Johnson in.. | AQ |
| 11/19 | GENMAB : EC Approves Expanded Darzalex Use in Multiple Myeloma | DJ |
| 11/18 | JOHNSON & JOHNSON : Janssen Leverages Wearable Technology to Reimagine Clinical .. | AQ |
| 11/18 | J&J Rushed to Test Safety of Baby Powder -- WSJ | DJ |
| 11/17 | JOHNSON & JOHNSON : J&J Rapidly Tested Its Baby Powder After Asbestos Finding --.. | DJ |
| 11/16 | Johnson & Johnson Opioid Verdict Cut -- WSJ | DJ |
| 11/15 | Johnson & Johnson's Oklahoma Opioid Penalty Reduced to $465 Million | DJ |
| 11/15 | JOHNSON & JOHNSON : Oklahoma judge reduces J&J order in opioid lawsuit by $107M | AQ |
| 11/15 | JOHNSON & JOHNSON : Oklahoma judge reduces amount Johnson & Johnson must pay sta.. | AQ |
| 11/13 | JOHNSON & JOHNSON : CARIBBEAN-POPULATION-International Population Summit opens i.. | AQ |
| 11/12 | JOHNSON & JOHNSON : Defendants in opioid case say politico's input not needed | AQ |
| 11/12 | JOHNSON & JOHNSON : TREMFYA a First-in-Class IL-23 p19 Subunit Inhibitor, Meets .. | AQ |
| 11/12 | JOHNSON & JOHNSON : Janssen Pharmaceutical - TREMFYA, a First-in-Class IL-23 p19.. | AQ |
| 11/11 | J&J'S JANSSEN : Tremfya Meets Main Endpoints in Psoriatic Arthritis Studies | DJ |
| 11/11 | JOHNSON & JOHNSON : New Analysis from Landmark CREDENCE Study Shows the Efficacy.. | AQ |
| 11/11 | JOHNSON & JOHNSON : Janssen Announces Submission of Supplemental New Drug Applic.. | AQ |
| 11/08 | JOHNSON & JOHNSON : J&J's Janssen Gets Health Canada OK for Expanded Imbruvica U.. | DJ |
| 11/08 | JOHNSON & JOHNSON : J&J's Janssen Seeks FDA OK for Expanded Imbruvica Use | DJ |
| 11/08 | JOHNSON & JOHNSON : Announces Submission of European Marketing Authorisation App.. | AQ |
| 11/07 | JOHNSON & JOHNSON : New York judge sets opioid crisis trial for January | AQ |
| 11/01 | JOHNSON & JOHNSON : Announces Donation of up to 500,000 Regimens of Janssen's In.. | AQ |
| 11/01 | JOHNSON & JOHNSON : Janssen Presenting Data from its Expanding Rheumatology Port.. | AQ |
| 10/29 | JOHNSON & JOHNSON : J&J Says Suspect Baby Powder Is Asbestos-Free -- Update | DJ |
| 10/29 | JOHNSON & JOHNSON : J&J says new tests find no asbestos in recalled baby powder | AQ |
| 10/29 | JOHNSON & JOHNSON : J&J Says Suspect Baby Powder Is Asbestos-Free | DJ |
| 10/29 | JOHNSON & JOHNSON : J&J Says Suspect Baby Powder Is Asbestos-Free | DJ |
| 10/29 | JOHNSON & JOHNSON : New Tests on Baby Powder Previously Tested by FDA Found No A.. | DJ |
| 10/28 | JOHNSON & JOHNSON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION .. | AQ |
| 10/26 | JOHNSON & JOHNSON : FG urged to improve school infrastructure | AQ |
| 10/25 | JOHNSON & JOHNSON : Retailers pull Johnson's baby powder after recall | AQ |
| 10/25 | JOHNSON & JOHNSON : FG urged to improve school infrastructure | AQ |
| 10/24 | CVS HEALTH : to Halt Sales of Some J&J Talcum Powder After Recall | DJ |
| 10/24 | CVS HEALTH : Pulls All 22-Ounce J&J Baby Powder From Stores -Bloomberg | DJ |
| 10/24 | JOHNSON & JOHNSON : Exclusive Interview with Cedric Gysel Johnson and Johnson's .. | AQ |
| 10/23 | JOHNSON & JOHNSON : J&J sets aside $4 billion for proposed opioid settlement | AQ |
| 10/23 | JOHNSON & JOHNSON : Results of Operations and Financial Condition, Regulation FD.. | AQ |
| 10/23 | JOHNSON & JOHNSON : Thinking about trading options or stock in Apple, Boeing, Ha.. | PR |
| 10/23 | JOHNSON & JOHNSON : J&J's Janssen Seeks European Expansion of Tremfya for Psoria.. | DJ |
| 10/22 | Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombs.. | RE |
| 10/22 | Health Care Up as Biogen Rallies -- Health Care Roundup | DJ |
| 10/22 | JOHNSON & JOHNSON : - STELARA Data Demonstrate Long-Term Efficacy and Safety Res.. | AQ |
| 10/22 | JOHNSON & JOHNSON : Janssen Announces U.S. FDA Approval of STELARA for the Treat.. | AQ |
| 10/22 | PROVENTION BIO : Says Crohn's Disease Treatment Misses Primary Endpoint | DJ |
| 10/22 | JOHNSON & JOHNSON : US baby powder recall not related to products in Philippines.. | AQ |
| 10/22 | JOHNSON & JOHNSON : Janssen Announces U.S. FDA Approval of STELARA ® (ustekinuma.. | PU |
| 10/22 | Opioid Deal Lifts Odds for Broader Accord -- WSJ | DJ |
| 10/21 | Drug firms avert landmark opioid trial as talks on $48 billion settlement set.. | RE |
| 10/21 | Drug firms avert landmark opioid trial as talks on $48-billion settlement set.. | RE |
| 10/21 | October brings losses for short sellers in U.S. opioid-related shares | RE |
| 10/21 | Billion-dollar lawsuits accuse drugmakers, distributors of fueling U.S. opioi.. | RE |
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report 
